Skip to main content
Clinical Trials/ACTRN12622000584730
ACTRN12622000584730
Active, not recruiting
未知

Prehabilitation and Supportive Care in Oncology Treatment of Breast Cancer (PROActive-B): a feasibility study of women with Breast cancer receiving neoadjuvant chemotherapy

Chris O'Brien Lifehouse Hospital0 sites23 target enrollmentApril 20, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Chris O'Brien Lifehouse Hospital
Enrollment
23
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 20, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Chris O'Brien Lifehouse Hospital

Eligibility Criteria

Inclusion Criteria

  • Study participant Group 1:
  • 1\. Female, aged over 18 years, diagnosed with breast cancer.
  • 2\. Has been identified as a patient for the NACT pathway by treating breast surgeon and/or medical oncologist.
  • 3\. Willingness to provide written consent and able to complete written study assessments and understand instruction for program in English.
  • Study participant Group 2:
  • 1\. HCP participants who have been involved in the program delivery.

Exclusion Criteria

  • 1\. Women lactating, pregnant or of childbearing potential who are not willing to avoid becoming pregnant during the study.
  • 2\. Unable to give informed consent
  • 3\. Has completed more than 2 cycles of neoadjuvant chemotherapy at time of enrolment
  • 4\. Unable to participate due to no computer at home or device to teleconference.
  • 5\. Contraindications to participation will be determine based on oncologist and exercise physiologist review based on the PAR\-Q and the Exercise and Sports Science Australia. The PAR\-Q\+ will be used as a preliminary tool. The PAR\-Q\+ is designed to identify symptoms or conditions requiring medical evaluation before participating in exercise. In this setting, cardiac risk is assessed to determine eligibility for NACT and medical records are reviewed before Exercise Physiology assessment. Additional information will be collected based on recommendations of Exercise and Sports Science Australia. These are outlined below:
  • Health history
  • physical activity and exercise history
  • cancer and non\-cancer co\-morbidities
  • expected treatment related toxicities
  • identification of patient capacity and contraindications

Outcomes

Primary Outcomes

Not specified

Similar Trials